It can revitalize tumor-infiltrating CD8+ T cells and up-regulate the expression of CTLA-4 and TIM-3 on depleted CD8+ T cells, resulting in high levels of CTLA-4+ Treg cells (39). This evidence concerns the gene HAVCR2 and neoplasm.